Session » 6W020: Miscellaneous Rheumatic & Inflammatory Disease III: Novel Therapies (2900–2905)
-
Abstract Number: 2900
Interferon Signature Predicts Response to Tofacitinib in Haploinsufficiency of A20
-
Abstract Number: 2901
Anakinra Treatment in Patients with Familial Mediterranean Fever: A Single-center Experience
-
Abstract Number: 2902
The Use and Safety of Rituximab in Connective Tissue Disease Associated Interstitial Lung Disease
-
Abstract Number: 2903
Cryopyrin-Associated Periodic Syndrome Treated with Canakinumab – Long-Term Follow-up Data Documents Sustained Safety and Remission
-
Abstract Number: 2904
Rituximab as Rescue Therapy in Treatment-Refractory CTD-ILD